My NCBI | Sign In
RSS Settings
  • Search: Hauke R[au]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 29

    1.

    Chronic bacterial inflammation induces prostatic intraepithelial neoplasia in mouse prostate.

    Elkahwaji JE, Hauke RJ, Brawner CM.

    Br J Cancer. 2009 Nov 17;101(10):1740-8. Epub 2009 Oct 20.PMID: 19844236 [PubMed - in process]Related articles

    2.

    Auditory location negative priming: a case of feature mismatch.

    Mayr S, Hauke R, Buchner A.

    Psychon Bull Rev. 2009 Oct;16(5):845-9.PMID: 19815787 [PubMed - in process]Related articles

    3.

    Suppression of ErbB-2 in androgen-independent human prostate cancer cells enhances cytotoxic effect by gemcitabine in an androgen-reduced environment.

    Zhang L, Davis JS, Zelivianski S, Lin FF, Schutte R, Davis TL, Hauke R, Batra SK, Lin MF.

    Cancer Lett. 2009 Nov 18;285(1):58-65. Epub 2009 May 24.PMID: 19467571 [PubMed - indexed for MEDLINE]Related articles

    4.

    New onset of heterophilic antibody interference in prostate-specific antigen measurement occurring during the period of post-prostatectomy prostate-specific antigen monitoring.

    Fritz BE, Hauke RJ, Stickle DF.

    Ann Clin Biochem. 2009 May;46(Pt 3):253-6. Epub 2009 Mar 5.PMID: 19264827 [PubMed - indexed for MEDLINE]Related articles

    5.

    No evidence for a cue mismatch in negative priming.

    Mayr S, Hauke R, Buchner A, Niedeggen M.

    Q J Exp Psychol (Colchester). 2009 Apr;62(4):645-52. Epub 2008 Dec 27.PMID: 19123117 [PubMed - indexed for MEDLINE]Related articles

    6.

    Improvement of cytotoxic effects induced by mitoxantrone on hormone-refractory metastatic prostate cancer cells by co-targeting epidermal growth factor receptor and hedgehog signaling cascades.

    Mimeault M, Mehta PP, Hauke R, Henichart JP, Depreux P, Lin MF, Batra SK.

    Growth Factors. 2007 Dec;25(6):400-16.PMID: 18365871 [PubMed - indexed for MEDLINE]Related articles

    7.

    Functions of normal and malignant prostatic stem/progenitor cells in tissue regeneration and cancer progression and novel targeting therapies.

    Mimeault M, Mehta PP, Hauke R, Batra SK.

    Endocr Rev. 2008 Apr;29(2):234-52. Epub 2008 Feb 21. Review.PMID: 18292464 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Novel C5a agonist-based dendritic cell vaccine in a murine model of melanoma.

    Floreani AA, Gunselman SJ, Heires AJ, Hauke RJ, Tarantolo S, Jackson JD.

    Cell Cycle. 2007 Nov 15;6(22):2835-9. Epub 2007 Aug 15.PMID: 17986862 [PubMed - indexed for MEDLINE]Related articles

    9.

    Recent advances in cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers.

    Mimeault M, Hauke R, Mehta PP, Batra SK.

    J Cell Mol Med. 2007 Sep-Oct;11(5):981-1011. Review.PMID: 17979879 [PubMed - indexed for MEDLINE]Related articles

    10.

    Recent advances on the molecular mechanisms involved in the drug resistance of cancer cells and novel targeting therapies.

    Mimeault M, Hauke R, Batra SK.

    Clin Pharmacol Ther. 2008 May;83(5):673-91. Epub 2007 Sep 5. Review.PMID: 17786164 [PubMed - indexed for MEDLINE]Related articles

    11.

    Prostate cancer. Clinical practice guidelines in oncology.

    Mohler J, Babaian RJ, Bahnson RR, Boston B, D'Amico A, Eastham JA, Hauke RJ, Huben RP, Kantoff P, Kawachi M, Kuettel M, Lange PH, Logothetis C, MacVicar G, Pollack A, Pow-Sang JM, Roach M 3rd, Sandler H, Shrieve D, Srinivas S, Twardowski P, Urban DA, Walsh PC; National Comprehensive Cancer Nerwork.

    J Natl Compr Canc Netw. 2007 Aug;5(7):650-83. No abstract available. PMID: 17692170 [PubMed - indexed for MEDLINE]Related articles

    12.

    Stem cells: a revolution in therapeutics-recent advances in stem cell biology and their therapeutic applications in regenerative medicine and cancer therapies.

    Mimeault M, Hauke R, Batra SK.

    Clin Pharmacol Ther. 2007 Sep;82(3):252-64. Epub 2007 Aug 1. Review.PMID: 17671448 [PubMed - indexed for MEDLINE]Related articles

    13.

    Treatment decisions for patients with non-Hodgkin's lymphoma: taking into account the type of lymphoma and clinical characteristics of the patient.

    Hauke RJ, Armitage JO.

    J BUON. 2002 Apr-Jun;7(2):99-105. No abstract available. PMID: 17577270 [PubMed - in process]Related articles

    14.

    Optimal management of small renal masses.

    Hauke R.

    J Natl Compr Canc Netw. 2006 Nov;4(10):1083-8. Review.PMID: 17112455 [PubMed - indexed for MEDLINE]Related articles

    15.

    Kidney cancer. Clinical practice guidelines in oncology.

    Motzer RJ, Bolger GB, Boston B, Carducci MA, Fishman M, Hancock SL, Hauke RJ, Hudes GR, Jonasch E, Kantoff P, Kuzel TM, Lange PH, Levine EG, Logothetis C, Margolin KA, Pohar K, Redman BG, Robertson CN, Samlowski WE, Sheinfeld J; National Comprehensive Cancer Network.

    J Natl Compr Canc Netw. 2006 Nov;4(10):1072-81. No abstract available. PMID: 17112454 [PubMed - indexed for MEDLINE]Related articles

    16.

    Testicular cancer. Clinical practice guidelines in oncology.

    Motzer RJ, Bolger GB, Boston B, Carducci MA, Fishman M, Hancock SL, Hauke RJ, Hudes GR, Jonasch E, Kantoff P, Kuzel TM, Lange PH, Levine EG, Logothetis C, Margolin KA, Pohar KS, Redman BG, Robertson CN, Samlowski WE, Sheinfeld J; National Comprehensive Cancer Network.

    J Natl Compr Canc Netw. 2006 Nov;4(10):1038-58. No abstract available. PMID: 17112452 [PubMed - indexed for MEDLINE]Related articles

    17.

    Kidney cancer. Clinical practice guidelines.

    Motzer RJ, Carducci MA, Fishman M, Hancock SL, Hauke RJ, Hudes GR, Kantoff P, Kuzel TM, Lange PH, Levine EG, Logothetis C, Margolin KA, Pili R, Pohar KS, Redman BG, Richey S, Robertson CN, Samlowski WE, Sheinfeld J, Urban DA; National Comprehensive Cancer Network.

    J Natl Compr Canc Netw. 2005 Jan;3(1):84-93. No abstract available. PMID: 19813325 [PubMed - in process]

    18.

    Testicular cancer. Clinical practice guidelines.

    Motzer RJ, Bahnson RR, Boston B, Carducci MA, Fishman M, Hancock SL, Hauke RJ, Hudes GR, Kantoff P, Kuzel TM, Lange PH, Levine EG, Logothetis C, Margolin KA, Redman BG, Richey S, Robertson CN, Samlowski WE, Sheinfeld J, Urban DA; National Comprehensive Cancer Network.

    J Natl Compr Canc Netw. 2005 Jan;3(1):52-76. No abstract available. PMID: 19813323 [PubMed - in process]

    19.

    ERK inhibitor PD98059 enhances docetaxel-induced apoptosis of androgen-independent human prostate cancer cells.

    Zelivianski S, Spellman M, Kellerman M, Kakitelashvilli V, Zhou XW, Lugo E, Lee MS, Taylor R, Davis TL, Hauke R, Lin MF.

    Int J Cancer. 2003 Nov 10;107(3):478-85.PMID: 14506750 [PubMed - indexed for MEDLINE]Related articles

    20.

    Weekly docetaxel and estramustine in patients with hormone-refractory prostate cancer.

    Sitka Copur M, Ledakis P, Lynch J, Hauke R, Tarantolo S, Bolton M, Norvell M, Muhvic J, Hake L, Wendt J.

    Semin Oncol. 2001 Aug;28(4 Suppl 15):16-21.PMID: 11685724 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    1 free full-text article in PubMed Central

    Find related data

    Search details

    » See more...

    Recent activity